🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fangyuan Chen

University of Pittsburgh

ORCID: 0000-0002-9891-4753

Also affiliated with Magee-Womens Research Institute, Dana-Farber Cancer Institute, First Affiliated Hospital of Xi'an Jiaotong University, Cancer Research Center, UPMC Hillman Cancer Center, Hainan Tropical Ocean University, Tsinghua University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.216Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00709-4
Top 63%
0.216DataRank
Top 63%3 citations

Fangyuan Chen, Li Chen, Jiebin Liu, Danielle Tseng, Fazal Hadi +14 more

Papers

Driven by 14 papers — median percentile 18. Top paper: “The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer”.

The EstroGene2.0 database for endocrine therapy response and resistance in breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00709-4
Top 63%
0.216DataRank
Top 63%3 citations

Fangyuan Chen, Li Chen, Jiebin Liu, Danielle Tseng, Fazal Hadi +14 more

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection

Molecular Systems Biology(2021)10.15252/msb.202110239
N/A
0DataRank · unranked
35 citations

Qingya Shi, Fen Pei, Andreas Vogt, Rebecca A. Porritt, Gustavo Garcia +11 more

Matching Patients to Clinical Trials with Large Language Models

PubMed(2023)10.48550/arxiv.2307.15051
N/A
0DataRank · unranked
42 citations

Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken‐Clarke +5 more

Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunities

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.26.559548
N/A
0DataRank · unranked
9 citations

Fangyuan Chen, Abdalla M. Wedn, Anokhi Kashiparekh, Beth A. Knapick, Jian Chen +8 more

Data from Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells

(2023)10.1158/0008-5472.c.6512673.v1
Top 100%
0DataRank
Top 100%0 citations

Kai Ding, Nolan Priedigkeit, Ashuvinee Elangovan, Kevin M. Levine, Neil Carleton +5 more

Matching patients to clinical trials with large language models

Nature Communications(2024)10.1038/s41467-024-53081-z
N/A
0DataRank · unranked
213 citations

Zifeng Wang, Charalampos S. Floudas, Fangyuan Chen, Changlin Gong, Dara Bracken‐Clarke +5 more

Hidden flaws behind expert-level accuracy of multimodal GPT-4 vision in medicine

npj Digital Medicine(2024)10.1038/s41746-024-01185-7
N/A
0DataRank · unranked
120 citations

Fangyuan Chen, Yiliang Zhou, Ziyang Xu, Justin M. Cheung, Robert F. Chen +13 more

International survey on invasive lobular breast cancer identifies priority research questions

npj Breast Cancer(2024)10.1038/s41523-024-00661-3
N/A
0DataRank · unranked
9 citations

Leigh Pate, Adrian V. Lee, Fangyuan Chen, Rachel C. Jankowitz, Rita A. Mukhtar +18 more

Immune infiltration correlates with transcriptomic subtypes in primary estrogen receptor positive invasive lobular breast cancer

npj Precision Oncology(2024)10.1038/s41698-024-00746-z
N/A
0DataRank · unranked
3 citations

Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore, Sai Maley +9 more

Hidden flaws behind expert-level accuracy of multimodal GPT-4 vision in medicine

PubMed(2024)10.48550/arxiv.2401.08396
N/A
0DataRank · unranked
2 citations

Fangyuan Chen, Yiliang Zhou, Ziyang Xu, Justin M. Cheung, Robert F. Chen +13 more

Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast Cancer

Research Square(2024)10.21203/rs.3.rs-4579052/v1
N/A
0DataRank · unranked
0 citations

Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore, Sai Maley +9 more

Supervising the search process produces reliable and generalizable information-seeking agents

ArXiv.org(2025)10.48550/arxiv.2502.13957
N/A
0DataRank · unranked
1 citations

Qiao Jin, Xiao Wang, Fang Yin, Haolin Liu, Yifan Yang +7 more

Single cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.21.959023
N/A
0DataRank · unranked
8 citations

Kai Ding, Nolan Priedigkeit, Ashuvinee Elangovan, Kevin M. Levine, Neil Carleton +5 more

Longitudinal ctDNA Surveillance in Older Women with ER+ Breast Cancer to Facilitate Surgical De-Escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies

medRxiv(2025)10.1101/2025.08.23.25332468
N/A
0DataRank · unranked
0 citations

Alexander Chih-Chieh Chang, Fangyuan Chen, Shannon Puhalla, Julia Foldi, Hunter Waltermire +21 more